Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ross David Carmel Insider Profile
4 Followers
Ross David Carmel, Chief Legal Officer at PsyBio Therapeutics, holds 1.74M shares in PsyBio Therapeutics (Ticker: TSE:PSYB.H). Most recently, Ross David Carmel Bought C$1,327,900 shares of PsyBio Therapeutics on Jan 13, 2023 for an estimated value of 66.39K.
Ross David Carmel has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Ross David Carmel's holdings
Insider Roles
Chief Legal Officer
Roles that Ross David Carmel holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Ross David Carmel
Ross David Carmel's Trading History
List of latest transactions for each holding click on a transaction to see Ross David Carmel's performance on stock
You May Also Like
Ross David Carmel insider profile FAQ
What is the percentage of profitable transactions made by Ross David Carmel?
The percentage of profitable transactions made by Ross David Carmel is ―.
What is the average return per transaction made by Ross David Carmel?
The average return per transaction made by Ross David Carmel is ―.
What stocks does Ross David Carmel hold?
Ross David Carmel holds: TSE:PSYB.H stocks.
What was Ross David Carmel’s latest transaction?
Ross David Carmel latest transaction was an Informative Buy of C$66.39K.
What was Ross David Carmel's most profitable transaction?
Ross David Carmel’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Ross David Carmel's role in PsyBio Therapeutics?
Ross David Carmel's role in PsyBio Therapeutics is Chief Legal Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.